v3.25.2
Condensed Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at Beginning at Dec. 31, 2023 $ 469,076 $ 16 $ 1,172,570 $ (76) $ (703,434)
Balance at Beginning (in Shares) at Dec. 31, 2023   158,832      
Issuance of common stock upon exercise of stock options 1,845   1,845    
Issuance of common stock upon exercise of stock options, shares   525      
Vesting of restricted common stock 41   41    
Unrealized loss on marketable debt securities (72)     (72)  
Stock-based compensation 7,373   7,373    
Net loss (53,721)       (53,721)
Balance at Ending at Mar. 31, 2024 424,542 $ 16 1,181,829 (148) (757,155)
Balance at Ending (in Shares) at Mar. 31, 2024   159,357      
Balance at Beginning at Dec. 31, 2023 469,076 $ 16 1,172,570 (76) (703,434)
Balance at Beginning (in Shares) at Dec. 31, 2023   158,832      
Unrealized loss on marketable debt securities (111)        
Net loss (112,421)        
Balance at Ending at Jun. 30, 2024 381,259 $ 16 1,197,285 (187) (815,855)
Balance at Ending (in Shares) at Jun. 30, 2024   159,950      
Balance at Beginning at Mar. 31, 2024 424,542 $ 16 1,181,829 (148) (757,155)
Balance at Beginning (in Shares) at Mar. 31, 2024   159,357      
Issuance of common stock upon exercise of stock options 2,654   2,654    
Issuance of common stock upon exercise of stock options, shares   598      
Forfeiture of restricted stock subject to repurchase, shares   (5)      
Vesting of restricted common stock 34   34    
Unrealized loss on marketable debt securities (39)     (39)  
Stock-based compensation 12,768   12,768    
Net loss (58,700)       (58,700)
Balance at Ending at Jun. 30, 2024 381,259 $ 16 1,197,285 (187) (815,855)
Balance at Ending (in Shares) at Jun. 30, 2024   159,950      
Balance at Beginning at Dec. 31, 2024 287,064 $ 16 1,234,207 62 (947,221)
Balance at Beginning (in Shares) at Dec. 31, 2024   161,710      
Forfeiture of unvested restricted common stock, shares   (231)      
Vesting of restricted stock units, shares   269      
Vesting of common stock subject to repurchase 33   33    
Unrealized loss on marketable debt securities (65)     (65)  
Stock-based compensation 9,324   9,324    
Net loss (67,992)       (67,992)
Balance at Ending at Mar. 31, 2025 228,364 $ 16 1,243,564 (3) (1,015,213)
Balance at Ending (in Shares) at Mar. 31, 2025   161,748      
Balance at Beginning at Dec. 31, 2024 287,064 $ 16 1,234,207 62 (947,221)
Balance at Beginning (in Shares) at Dec. 31, 2024   161,710      
Unrealized loss on marketable debt securities (77)        
Net loss (120,723)        
Balance at Ending at Jun. 30, 2025 182,879 $ 16 1,250,822 (15) (1,067,944)
Balance at Ending (in Shares) at Jun. 30, 2025   161,947      
Balance at Beginning at Mar. 31, 2025 228,364 $ 16 1,243,564 (3) (1,015,213)
Balance at Beginning (in Shares) at Mar. 31, 2025   161,748      
Vesting of restricted stock units, shares   102      
Vesting of common stock subject to repurchase 34   34    
Issuance of common stock upon exercise of stock options 59   59    
Issuance of common stock upon exercise of stock options, shares   97      
Unrealized loss on marketable debt securities (12)     (12)  
Stock-based compensation 7,165   7,165    
Net loss (52,731)       (52,731)
Balance at Ending at Jun. 30, 2025 $ 182,879 $ 16 $ 1,250,822 $ (15) $ (1,067,944)
Balance at Ending (in Shares) at Jun. 30, 2025   161,947